Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?
CONCLUSIONS: In this study, two thirds of the patients continued nevirapine with favourable long-term tolerability and efficacy. Thus, this low-cost “old drug” may still represent a valid treatment switch option for maintenance therapy in selected patients with a fully suppressed viral load. However, further evaluation is needed.  .
PMID: 31017649 [PubMed - in process]
Source: Swiss Medical Weekly - Category: General Medicine Authors: Notter J, Bregenzer A, Vernazza P, Kahlert CR Tags: Swiss Med Wkly Source Type: research
More News: Drugs & Pharmacology | General Medicine | Hepatitis | Hepatitis C | Liver | Skin | Study | Switzerland Health | Urology & Nephrology | Women